Chris Green

To ask the Secretary of State for Health and Social Care, what recent estimate he has made of how many immunocompromised individuals of (a) working age and (b) all ages are continuing to shield against covid-19; and whether he has made a recent assessment...

To ask the Secretary of State for Health and Social Care, how many NHS beds have been occupied by immunocompromised patients (a) who are of working age and (b) in total and who were admitted for covid-19 in 2022.

To ask the Secretary of State for Health and Social Care, how many immunocompromised individuals of (a) working age and (b) all ages have been (i) hospitalised with and (ii) died of covid-19 in 2022.

To ask the Secretary of State for Health and Social Care, how many doses of covid-19 antivirals have been administered to (a) immunocompromised individuals and (b) people of working age after contracting covid-19 during the period of 17 March 2022 to 17 M...

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 March to Question 141960, whether he can provide an estimated date for the availability of Evusheld on the NHS.

To ask the Secretary of State for Health and Social Care, what assessment the Government has made of the potential merits of reversing compulsory covid-19 vaccination requirements in all sectors that contain them.

To ask the Secretary of State for Health and Social Care, how many people were recruited into National Institute for Health and Care Research supported phase 3 trials for (a) dementia, (b) cancer, (c) stroke and (d) coronary heart disease in each of the l...

To ask the Secretary of State for Health and Social Care, how many women have been enrolled in (a) cancer, (b) stroke and (c) dementia clinical trials in each year since 2017.

To ask the Secretary of State for Health and Social Care, how many women have been enrolled in (a) cancer, (b) stroke and (c) dementia clinical trials in each year since 2017.

To ask the Secretary of State for Health and Social Care, how many participants were recruited into National Institute for Health and Care Research supported phase 3 trials for (a) dementia, (b) cancer, (c) stroke and (d) coronary heart disease in each of...

To ask the President of COP26, what progress he made at COP26 on reducing the use of coal.

To ask the Secretary of State for Health and Social Care, whether he is taking steps to deliver on the manifesto commitment to double research funding into dementia.

To ask the Secretary of State for Health and Social Care, how many participants were recruited into NIHR supported phase 3 trials for (a) dementia, (b) cancer, (c) stroke and (d) coronary heart disease over the last 10 years.

To ask the Secretary of State for Business, Energy and Industrial Strategy, when the Global Britain Investment Fund will open for investment for new medicines manufacturing; and what steps he is taking to ensure that the fund supports innovative, smaller ...

To ask the Secretary of State for Health and Social Care, what progress he has made on the implementation of the proposals in his Department's policy paper, Saving and Improving Lives: The Future of UK Clinical Research Delivery; and what funding has been...

To ask the Secretary of State for Health and Social Care, if he will take steps to implement the strategy set out in his Department's policy paper, Saving and Improving Lives: The Future of UK Clinical Research Delivery, to ensure the attractiveness of th...

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 January 2022 to Question 96909, on Cancer: Drugs, how many breast cancer drugs are being assessed through the Project Orbis licensing route.

To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) technology capability and (b) workforce expertise in each of the genomic laboratory hubs; and if he will publish that assessment.

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 January 2022 to Question 96910 on National Institute for Health and Care Excellence, how many oncology technical appraisals have been rescheduled in the last six months...

To ask the Chancellor of the Exchequer, what discussions he has had with the life sciences sector to discuss the issue of territoriality for R&D tax relief.